Furthermore, we obtained that breast cancer patients with high levels of CD4/CD8 ratio ( > 1.2) had significantly poor cancer-specific OS and RFS probabilities, which was very similar as those in CD4+ T cells (Figure 5C). This evidence concerns the gene CD8A and breast cancer.